Date updated:08-14-2007
Analysis (superficial) of stocks hitting new 52-week lows.

-
SYMM
Symmetricom - $6.10
- -3.33%
- $6.33
Got beat up for earnings misses, which appear to be tied to timing of purchases from major telecomm carrier spending - major customers like T VZ have delayed synchronization upgrades (whatever they are). Probably a 2 down/5 up risk profile. Closed at 5.06 on Aug 10

-
DNA
N/a - $80.43
- 0.00
- $80.43
Per WSJ, most of bio-tech gains come in the autumn because: (1) prices are driven by clinic trial results, not financials (2) companies like to announce results at conferences, and the largest biotech conferences are in the fall (3) companies push to submit FDA filings before year-end so they can be referenced in annual reports (4) FDA takes 6-12 months to review filings, so their results come out in the 2nd half (following #3) Closed at71.67 on Aug 10

-
WYE
Wyeth - $50.39
- 0.00%
- $N/A
Same rationale as for DNA Closed at 46.55 on Aug 10

-
CTRN
Citi Trends - $33.17
- -2.38%
- $33.54
Beaten-up stock in a beaten-up sector, and recently downgraded. Would be worth further analysis, if only because George Soros just announced a 6.6% stake in the company. Closed at 23.80 on Aug 14

-
UBS
Ubs Ag Common Sto - $15.73
- +0.58%
- $15.91
Great investment bank, but tough time for financials. Big question is, is this 52-week low the bottom for UBS? Closed at 51.00 after hours on August 14
- 52-Week Low Analysis: Marc_In_Oregon's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Fidelity Select Pharma...
- 3. Calamos Advisors
- 4. BlackRock Health Scien...
- 5. Schwab Health Care SWHFX
- show all
- Top Do-It-Yourself Portfolios
- » jgroov Portfolio 1
- » ben johnson
- » my holdings
- » SC TRADE OF THE DAY
- » kudos
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Jonas Elmerraji Posted on March 19, 2010 Last week was a comparatively quiet one for dividend stocks, particularly given the slew of investor payouts that capped off...
By Roberto Pedone Posted on March 19, 2010 According to Jim Cramer, the stock market could catch a cold from health care reform. In a March 18 RealMoney blog post, he s...
By Jonas Elmerraji Posted on March 18, 2010 Short sellers beware; stocks are seeing a buyer’s market this week. Now that the S&P 500 and the Dow Jones Industrial Aver...
By Roberto Pedone Posted on March 18, 2010 According to CNBC’s “Fast Money” traders, the easy money trades are still the way to play this market after the Federal...
A. Just to be clear, the notices are for
the same answer.
A. The only one I own : SLX,
too hard pick a winner out all of them
Analyst Upgrades and EPS estimate changes for Mar. 19, 2010. more
Below is the list of the top open-market insider buys filed at the SEC on Mar. 18, 2010. more
These are the stocks from Jim Cramer's Mar. 18 Lightning Round. We list the stocks on which he is BULLISH and BEARISH.... more











Comments not available